TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

$0.59
-0.02 (-3.25%)
As of Sep 28, 10:16 PM ET ·
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Buy 12 92%
Hold 1 8%
Sell 0 0%
Price Target
Analyst Price Target +6,029.2% upside
Low Target $26.32
Average Target $36.15
High Target $48.95
Current Price $0.59
Current
$0.59
Target
$36.15
$26.32 $36.15 avg $48.95
Scenario Analysis
Bear Case
$26.32
4,362.5%
Low target
Base Case
$36.15
+6,029.2%
Avg target
Bull Case
$48.95
+8,199.4%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.35
-74.9% from high
52-Week Low
$0.53
+10.9% from low
Target vs 52W High
$36.15
+1,438.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%